Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04454762
Title A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function (CaboCHILD)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johannes Gutenberg University Mainz
Indications

hepatocellular carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.